Skip to main content
. 2023 Nov 14;12:52. doi: 10.1186/s40035-023-00385-7

Table 2.

Current therapeutic approaches targeting OPCs in AD mice

Therapeutic approach Species Target Description References
Senolytic APP/PS1 transgenic mice Senescent OPCs Utilizes compounds that can selectively clear senescent OPC [18]
Rejuvenation Hemizygous hAPP-J20 mice Senescent OPCs Mitigates OPC aging by overexpressing anti-aging gene KLOTHO [209]
Promotion of cell differentiation 3×Tg-AD mice OPC differentiation-related pathways Promotes OPC differentiation with RXR agonist [216]
APP/PS1 transgenic mice Promotes OPC differentiation with mTOR inhibitor [15]